Chinibes 40 (Number 544) (Paramesh Banerji Life Sciences LLC)


Welcome to the PulseAid listing for the Chinibes 40 (Number 544) drug offered from Paramesh Banerji Life Sciences LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Paramesh Banerji Life Sciences LLC
NON-PROPRIETARY NAME: Lycopodium clavatum, Chelidonium majus
SUBSTANCE NAME: LYCOPODIUM CLAVATUM SPORE; CHELIDONIUM MAJUS
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2014-10-18
END MARKETING DATE: 0000-00-00


Chinibes 40 (Number 544) HUMAN OTC DRUG Details:

Item DescriptionChinibes 40 (Number 544) from Paramesh Banerji Life Sciences LLC
LABELER NAME: Paramesh Banerji Life Sciences LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 30; 200([hp_C]/1; [hp_C]/1)
START MARKETING DATE: 2014-10-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69152-0544_4104d57b-f1c9-442e-e054-00144ff88e88
PRODUCT NDC: 69152-0544
APPLICATION NUMBER:

Other LYCOPODIUM CLAVATUM SPORE; CHELIDONIUM MAJUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Paramesh Banerji Life Sciences LLCChinibes 40 (Number 544)